The eHealth Diary: digital pen telemonitoring of patients with advanced chronic obstructive pulmonary disease (COPD) and heart failure within specialised home care

ISRCTN ISRCTN34252610
DOI https://doi.org/10.1186/ISRCTN34252610
Secondary identifying numbers N/A
Submission date
31/10/2013
Registration date
12/11/2013
Last edited
03/11/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study aims to investigate whether the use of digital pen technology for reporting of symptoms and measurement values from the home care patient to the professional care provider can improve the care of patients with severe chronic obstructive pulmonary disease (COPD) and/or heart failure (HF).

Who can participate?
Patients > 65 years admitted to hospital care at least two times during the last 12 months

What does the study involve?
All patients report daily on symptoms, measurements, and intake of medications using a digital pen and a Health Diary form. The patients also fill in questionnaires related to quality of life and the technology and method used.

What are the possible benefits and risks of participating?
Reporting on one’'s health condition each day will support the professional care providers to detect early signs of worsening of the health condition. Possible risks of being included in the study are that it can be tiresome to fill in the questionnaires.

Where is the study run from?
The study will be performed at the hospital-based home care clinic, Linköping University Hospital (Sweden).

When is the study starting and how long is it expected to run for?
November 2013 to December 2017

Who is funding the study?
The study is funded by the County Council of Östergötland, The European Regional Development Fund through the NovaMedTech venture and the Swedish ICT Research (Sweden).

Who is the main contact?
Dr Leili Lind
Leili.Lind@liu.se

Study website

Contact information

Dr Leili Lind
Scientific

SICS East Swedish ICT & Department of Biomedical Engineering
Linköping University
Linköping
58185
Sweden

Email leili.lind@liu.se

Study information

Study designIntervention non-randomized single-centre clinical study compared with expected outcomes
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet (available in Swedish)
Scientific titleTelemonitoring of patients with advanced COPD and heart failure within specialised home care - based on digital pen technology and a Health Diary form
Study acronymThe eHealth Diary
Study objectivesThe hypothesis is that special home healthcare and use of the telehealth system will detect early signs of deterioration of heart failure and COPD and monitor drug intake, and thereby decrease acute hospital re-admissions and increase the patients’ quality of life.
Ethics approval(s)Regional Ethical Review Board in Linköping, Sweden, 17/09/2013
Health condition(s) or problem(s) studiedCOPD and/or heart failure
InterventionThis is a non-randomized single-centre study following an intervention group only. Expected outcomes will be calculated based on historical data from patients with the same characteristics out of data from our administrative register. The expected outcomes will be compared with the actual from our intervention group. This method is inspired from a discontinuity regression model, which is an alternative when randomisation is not feasible due to logistic and ethical reasons. Therefore this is an intervention clinical study compared with expected outcomes.

Study patients will report daily on various symptoms and measurement values (such as shortness of breath, cough, mucous, weight, blood pressure, pulse, oxygen saturation) and intake of p.r.n. medications, using a digital pen and a Health Diary form. The Health Diary form also allows free text messages from the patients.

Healthcare personnel will monitor the system and incoming patient reports on a daily basis. Alarms will be generated if a patient reports values outside of predetermined limits or if a patient fails to send in reports.

Patients will be asked to fill in the following questionnaires: (Swedish versions of) St George's Respiratory Questionnaire/Minnesota Living with heart failure questionnaire, the ED-5Q questionnaire and the SF-36 (at baseline, 1, 6 and 12 months), and eHealth Diary-related questionnaires (at 1, 6 and 12 months).

COPD patients will be asked to also fill in mMRC and COPD Assessment Test (CAT) at baseline.
Intervention typeOther
Primary outcome measureAll outcomes measured at 12 months using patient records/administrative registers:
1. Number of hospital admissions
2. Healthcare costs
3. Mortality
Secondary outcome measures1. Health-related quality of life, measured– using questionnaires at baseline, 1, 6 and 12 months
2. Patients’ ability to handle the technology and method, measured– using questionnaires at 1, 6 and 12 months
3. Patients’ participation in their own care, measured– using questionnaires at baseline, 1, 6 and 12 months
4. Patients’ knowledge of their illness, measured– using questionnaires at baseline, 1, 6 and 12 months
5. Patients’ feeling of security, measured– using questionnaires at baseline, 1, 6 and 12 months
6. Deterioration and exacerbations, measured– using patient records at baseline, 1, 6 and 12 months
Overall study start date11/11/2013
Completion date02/12/2017

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants130
Key inclusion criteriaCurrent inclusion criteria as of 08/05/2014:
1. Patients (men and women) > 65 years diagnosed with COPD and/or heart failure
2. With >= 2 hospital admissions during the last 12 months

Previous inclusion criteria:
1. Patients (men and women) > 65 years diagnosed with COPD and/or heart failure
2. With >= 3 hospital admissions due to COPD/heart failure during the last 12 months
Key exclusion criteria1. Dementia/other cognitive impairment or psychotic illness
2. Lack of ability to understand Swedish
3. Severe hearing loss
4. Underwent surgery in the last 6 months or surgery planned in the next 6 months
5. Other life-threatening illness
Date of first enrolment11/11/2013
Date of final enrolment30/11/2016

Locations

Countries of recruitment

  • Sweden

Study participating centre

Linköping University
Linköping
58185
Sweden

Sponsor information

Linköping University (Linköpings universitet) (Sweden)
University/education

Department of Biomedical Engineering &
Department of Medical and Health Sciences
Linköping
58185
Sweden

Website http://www.imt.liu.se/
ROR logo "ROR" https://ror.org/05ynxx418

Funders

Funder type

Government

The County Council of Östergötland (Sweden)

No information available

The European Regional Development Fund through the NovaMedTech venture (Sweden)

No information available

Swedish ICT Research (Sweden)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

03/11/2017: The overall trial end date was changed from 30/11/2016 to 02/12/2017.